- Cannabis Sector Mixed Signals on Policy - Jan 13A coordinated pushback warning rattled the cannabis narrative today, but policy wins and federal data offset some concern. New Jersey approved a funded psilocybin pilot and federal survey findings ease youth-use fears.
- Cannabis Sector Sees Growth Signals - Jan 12Texas medical cannabis expansion and Ohio topping $1.09B in first full adult-use year drove the day’s headlines, offset by regulatory questions over hemp-derived THC and a Maine repeal petition. Investors should watch Texas rulemaking, Maine ballot activity and next-state sales updates.
- Cannabis Sector Eyes DOJ Rescheduling Move - Jan 12Federal momentum returned Monday as a GOP lawmaker said the DOJ won’t delay cannabis rescheduling, while state-level actions in Florida, Kentucky and Massachusetts add near-term catalysts. Investors should watch policy timing and MSO exposure today.
- Cannabis Sector: Pre-Rolls Growth vs. Regulation - Jan 11Retail momentum from pre-rolls is getting fresh attention as a tangible sales driver, while state-level regulatory fights in Wisconsin underscore continuing policy risk. Investors should weigh near-term retail upside against patchwork hemp THC rules.
- Cannabis: Sales Milestone, Banking Headwinds - Jan 9Massachusetts reached $10B in lifetime cannabis sales and posted a record $1.65B in 2025, but big banks still shun the industry despite federal rescheduling. Operators face pricing pressure, compliance costs and watch for state-level rollout progress.
- Cannabis Sector Gains on Federal Protections - Jan 9Congress approved federal medical cannabis protections today, a major policy shift that could expand markets and ease banking and research. Celebrity-brand fraud claims add a legal reminder for investors to watch licensing and reputational risk.
- Cannabis Sector Gains Momentum - Jan 8Tilray reported record Q2 revenue and moved to net cash while the U.S. House cleared a path for federal rescheduling, lifting sector sentiment. State-level price pressure and a Massachusetts ballot review keep risks in view.
- Cannabis Policy Momentum and Supply Woes - Jan 7State-level legalization momentum met operational hiccups today as Kentucky supply shortfalls contrasted with New Hampshire and Hawaii reform moves and a federal plea for full legalization. Investors should watch state ballots, supply logistics and federal guidance next.
- Cannabis Policy Shifts Drive Risk for Investors - Jan 6A flurry of state and federal policy moves on Jan 6 shifted the narrative for cannabis investors: Florida proposals threaten patient registrations, the Senate confirmed an ONDCP director, and Indiana filed a low‑level legalization bill. These developments tighten regulatory risk in key markets while offering potential upside if rescheduling momentum continues.
- Cannabis Sector Updates: Wyld's Acquisition & Sales Trends - Jan 6Today's cannabis sector highlights include Wyld's acquisition of Grön and slow sales growth in December. Investors should monitor regulatory developments and market trends.